Patents by Inventor Alan John Michelich

Alan John Michelich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220270735
    Abstract: Computing system for providing medication dose guidance recommendations to a plurality of subjects using a multi-function dose guidance algorithm comprising a plurality of functions, wherein each respective function in the plurality of functions is associated with a corresponding container class.
    Type: Application
    Filed: August 27, 2019
    Publication date: August 25, 2022
    Inventors: Alan John Michelich, Thomas Dedenroth Miller
  • Publication number: 20220023391
    Abstract: The invention relates to an administration regimen useful in the treatment of diseases or conditions where administration of insulin will be of benefit. In particular, the invention relates to a long-acting or ultra-long acting insulin for use in treating a disease or condition where administration of insulin will be of benefit, wherein the administration of said insulin includes or consists of one or more of the following steps: (a) obtaining a first data set of the subject, (b) obtaining a second data set of the subject, (c) obtaining a first data structure of the subject, and (d) obtaining a second data structure of the subject. When a determination is made that the at least first data structure, second data structure, first data set, and second data set collectively do contain the set of evaluation information, the method further includes providing the long-acting or ultra-long-acting insulin dose guidance recommendation.
    Type: Application
    Filed: June 26, 2019
    Publication date: January 27, 2022
    Inventors: Alan John Michelich, Thomas Dedenroth Miller, Oleksandr Shvets, Anuar Imanbayev, Brad Warren Van Orden
  • Publication number: 20210142879
    Abstract: Systems and methods for communicating a dose history configured for representing a central tendency and a variability of a distribution of injections with a blood glucose regulating medicament.
    Type: Application
    Filed: February 6, 2018
    Publication date: May 13, 2021
    Inventors: Pete Brockmeier, Michael Friis, Alan John Michelich, Tinna Bjoerk Aradottir, Henrik Bengtsson
  • Publication number: 20190388512
    Abstract: The invention relates to a novel administration regime useful in the treatment of diseases or conditions where administration of insulin will be of benefit. In particular, the invention relates to a long-acting or ultra-long acting insulin for use in treating a disease or condition where administration of insulin will be of benefit, wherein the administration of said insulin includes or consists of one or more of the following steps: (a) obtaining a first data set of the subject, (b) obtaining a second data set of the subject, (c) obtaining a first data structure of the subject, and (d) obtaining a second data structure of the subject. When a determination is made that the at least first data structure, second data structure, first data set, and second data set collectively do contain the set of evaluation information, the device further includes providing the long-acting or ultra-long-acting insulin dose guidance recommendation.
    Type: Application
    Filed: May 20, 2019
    Publication date: December 26, 2019
    Inventors: Alan John Michelich, Thomas Dedenroth Miller, Oleksandr Shvets, Anuar Imanbayev, Brad Warren Van Orden
  • Patent number: 10335464
    Abstract: The invention relates to a novel administration regime useful in the treatment of diseases or conditions where administration of insulin will be of benefit. In particular, the invention relates to a long-acting or ultra-long acting insulin for use in treating a disease or condition where administration of insulin will be of benefit, wherein the administration of said insulin includes or consists of one or more of the following steps: (a) obtaining a first data set of the subject, (b) obtaining a second data set of the subject, (c) obtaining a first data structure of the subject, and (d) obtaining a second data structure of the subject. When a determination is made that the at least first data structure, second data structure, first data set, and second data set collectively do contain the set of evaluation information, the device further includes providing the long-acting or ultra-long-acting insulin dose guidance recommendation.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: July 2, 2019
    Assignee: Novo Nordisk A/S
    Inventors: Alan John Michelich, Thomas Dedenroth Miller, Oleksandr Shvets, Anuar Imanbayev, Brad Van Orden